AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37044318 — intervention group
Group type: EXPERIMENTAL
Intervention: t-Branch graft
Number of subjects: 80
Study 37044364 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted strategy with a multidisciplinary approach including telehealth tools, continued education, pharmacological and non-pharmacological treatment, and behavioral change.
Number of subjects: 35
Study 37044364 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 35
Study 37045473 — intervention group
Group type: EXPERIMENTAL
Intervention: Adoptive transfer of autologous tumor infiltrating lymphocytes (TILs) that recognize tumor-specific point mutations.
Number of subjects: 0
Study 37045473 — intervention group
Group type: EXPERIMENTAL
Intervention: TILs targeting cancer-specific mutations and other genetic aberrations such as gene fusions.
Number of subjects: 0
Study 37045498 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB-only angioplasty
Number of subjects: 1139
Study 37045498 — intervention group
Group type: COMPARATOR
Intervention: DES
Number of subjects: 1139
Study 37045500 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated antiplatelet therapy (APT)
Number of subjects: 4579
Study 37045500 — intervention group
Group type: COMPARATOR
Intervention: Standard antiplatelet therapy (APT)
Number of subjects: 4579
Study 37045500 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care period
Number of subjects: 4579
Study 37045504 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C19 genotyping with clopidogrel-based therapy (RMs or NMs)
Number of subjects: 8163
Study 37045504 — intervention group
Group type: COMPARATOR
Intervention: CYP2C19 genotyping with clopidogrel-based therapy (IMs or PMs)
Number of subjects: 8163
Study 37045543 — intervention group
Group type: EXPERIMENTAL
Intervention: DTI-ALPS index (first quartile)
Number of subjects: 2219
Study 37045544 — intervention group
Group type: EXPERIMENTAL
Intervention: Catfish stent retriever
Number of subjects: 238
Study 37045546 — intervention group
Group type: EXPERIMENTAL
Intervention: Salpingectomy with delayed oophorectomy
Number of subjects: 1500
Study 37045546 — intervention group
Group type: COMPARATOR
Intervention: Salpingo-oophorectomy
Number of subjects: 1500
Study 37045565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine or Epinephrine administration
Number of subjects: 0
Study 37045565 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusion
Number of subjects: 0
Study 37045569 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (1.6%) + chondroitin sulfate (2%) therapy (Ialuril)
Number of subjects: 80
Study 37045570 — intervention group
Group type: EXPERIMENTAL
Intervention: Hidden pain conditioning with positive induced expectations (G1)
Number of subjects: 264
Study 37045570 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expectations (G2)
Number of subjects: 264
Study 37045570 — intervention group
Group type: COMPARATOR
Intervention: Neutral expectations (G3)
Number of subjects: 264
Study 37045574 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID Psychosocial Impacts Scale (CPIS)
Number of subjects: 3500
Study 37045574 — intervention group
Group type: EXPERIMENTAL
Intervention: Established measures of psychological distress, post-traumatic stress, well-being, and post-traumatic growth
Number of subjects: 3500
Study 37045708 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN) 4.5 mg for 8 weeks
Number of subjects: 23
Study 37045708 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 23
Study 37045845 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous spinal cord epidural stimulation (SCES)
Number of subjects: 2
Study 37045845 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary SCES implantation
Number of subjects: 2
Study 37045845 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent SCES implantation
Number of subjects: 2
Study 37046093 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 37046095 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 37046094 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies against endogenous retroviruses
Number of subjects: 0
Study 37046096 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 37046122 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g per day I + AX for 21 days
Number of subjects: 20
Study 37046122 — intervention group
Group type: COMPARATOR
Intervention: Weight-matched maltodextrin control
Number of subjects: 20
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP users
Number of subjects: 2567
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger participants
Number of subjects: 2567
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with lower self-esteem
Number of subjects: 2567
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with higher depression scores
Number of subjects: 2567
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants encouraged by their main partner
Number of subjects: 2567
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants encouraged by friends
Number of subjects: 2567
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with knowledge of their partner's HIV status
Number of subjects: 2567
Study 37046178 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants using PrEP and/or condoms
Number of subjects: 2567
Study 37046213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 23
Study 37046213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV)
Number of subjects: 23
Study 37046213 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous breathing (SB) after extubation
Number of subjects: 23
Study 37046213 — intervention group
Group type: COMPARATOR
Intervention: Controlled ventilation
Number of subjects: 23
Study 37046213 — intervention group
Group type: EXPERIMENTAL
Intervention: Restart of spontaneous breathing
Number of subjects: 23
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: XGBoost pre-pandemic model
Number of subjects: 0
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning pre-pandemic model
Number of subjects: 0
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: XGBoost during first pandemic wave
Number of subjects: 0
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning during first pandemic wave
Number of subjects: 0
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: XGBoost augmented with first wave data
Number of subjects: 0
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning augmented with first wave data
Number of subjects: 0
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: XGBoost first phase after re-training
Number of subjects: 0
Study 37046259 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning first phase after re-training
Number of subjects: 0
Study 37046290 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (CBT) for tinnitus
Number of subjects: 0
Study 37046290 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered mindfulness-based tinnitus stress reduction intervention (MBTSR)
Number of subjects: 0
Study 37046290 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 0
Study 37046343 — intervention group
Group type: EXPERIMENTAL
Intervention: LACI (left atrioventricular coupling index) assessment
Number of subjects: 1046
Study 37046343 — intervention group
Group type: EXPERIMENTAL
Intervention: LACI cut-off at 34.7%
Number of subjects: 1046
Study 37046343 — intervention group
Group type: EXPERIMENTAL
Intervention: LACI
Number of subjects: 1046
Study 37046343 — intervention group
Group type: EXPERIMENTAL
Intervention: LACI assessment in high-risk patients with impaired LV systolic function (LVEF ≤ 35%)
Number of subjects: 1046
Study 37046380 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 72
Study 37046380 — intervention group
Group type: COMPARATOR
Intervention: Control (CTR)
Number of subjects: 72
Study 37046452 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 60
Study 37046452 — intervention group
Group type: COMPARATOR
Intervention: Gemifloxacin
Number of subjects: 60
Study 37046466 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon-performed POCUS
Number of subjects: 100
Study 37046681 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (6 mg/kg/day) with Celecoxib (fixed daily dose)
Number of subjects: 20
Study 37046849 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab combined with 5-fluorouracil and cisplatin (6 cycles)
Number of subjects: 65
Study 37047973 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) interventions
Number of subjects: 0
Study 37047973 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 37048055 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 46
Study 37048055 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-28-3p, miR-139-5p, miR-376a-3p (after follow-up)
Number of subjects: 46
Study 37048055 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 46
Study 37048055 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-139-5p
Number of subjects: 46
Study 37048135 — intervention group
Group type: EXPERIMENTAL
Intervention: Copeptin
Number of subjects: 219
Study 37048135 — intervention group
Group type: COMPARATOR
Intervention: hs-cTnT
Number of subjects: 219
Study 37048135 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of copeptin and hs-cTnT
Number of subjects: 219
Study 37048135 — intervention group
Group type: COMPARATOR
Intervention: Acute HF
Number of subjects: 219
Study 37048135 — intervention group
Group type: COMPARATOR
Intervention: NSTE-ACS
Number of subjects: 219
Study 37048135 — intervention group
Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 219
Study 37048598 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic median nerve stimulation (MNS) at 10 Hz
Number of subjects: 32
Study 37048598 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic median nerve stimulation (MNS) at 12 Hz
Number of subjects: 32
Study 37048598 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrhythmic median nerve stimulation (MNS) at 12 Hz
Number of subjects: 32
Study 37048598 — intervention group
Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 32
Study 37048629 — intervention group
Group type: EXPERIMENTAL
Intervention: Median Nerve Stimulation (MNS) at 12 Hz for 4 weeks
Number of subjects: 31
Study 37048629 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) unit for MNS
Number of subjects: 31
Study 37049546 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychobiotics
Number of subjects: 0
Study 37049546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 37049576 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplement (probiotics, prebiotics, vitamin D, zinc, and selenium)
Number of subjects: 162
Study 37050861 — intervention group
Group type: EXPERIMENTAL
Intervention: Venglustat administered as food admixture
Number of subjects: 0
Study 37050937 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma ceramide levels (C16:0, C18:0, C20:0, C24:1, C24:2) measured at admission
Number of subjects: 826
Study 37050937 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Global Registry of Acute Coronary Events (GRACE) score with ceramides
Number of subjects: 826
Study 37050937 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain ceramides and very-long-chain ceramides measurements
Number of subjects: 826
Study 37051014 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' estimates of others' cannabis use (weekly or more often)
Number of subjects: 744
Study 37051014 — intervention group
Group type: COMPARATOR
Intervention: General population survey reports of cannabis use
Number of subjects: 744
Study 37051129 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN) from postoperative day 1 to day 5 plus oral food 'at will' (treatment arm)
Number of subjects: 0
Study 37051129 — intervention group
Group type: COMPARATOR
Intervention: Oral food 'at will' alone (control arm)
Number of subjects: 0
Study 37051203 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal group (n=300)
Number of subjects: 468
Study 37051203 — intervention group
Group type: COMPARATOR
Intervention: Muscular/pain group (n=73)
Number of subjects: 468
Study 37051564 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation programme combined with continuous positive airway pressure
Number of subjects: 180
Study 37051564 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure alone
Number of subjects: 180
Study 37051564 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 180
Study 37051646 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus ovarian function suppression (T+OFS group)
Number of subjects: 39
Study 37051646 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (T group)
Number of subjects: 39
Study 37051752 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD-EPI creatinine-cystatin equation
Number of subjects: 1966
Study 37051752 — intervention group
Group type: COMPARATOR
Intervention: Creatinine-only equation
Number of subjects: 1966
Study 37051752 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (lower eGFR with creatinine-cystatin)
Number of subjects: 1966
Study 37051752 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (higher eGFR with creatinine-cystatin)
Number of subjects: 1966
Study 37051752 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing difference in eGFR (due to lower eGFR with creatinine-cystatin)
Number of subjects: 1966
Study 37051756 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax 600 mg daily with azacitidine during induction cycles; maintenance arms included azacitidine with 400 mg venetoclax or 400 mg venetoclax alone.
Number of subjects: 42
Study 37051756 — intervention group
Group type: EXPERIMENTAL
Intervention: MRD-negative patients by flow cytometry
Number of subjects: 42
Study 37051756 — intervention group
Group type: COMPARATOR
Intervention: MRD guidance for azacitidine discontinuation
Number of subjects: 42
Study 37051756 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax doses >400 mg with azacitidine
Number of subjects: 42
Study 37051799 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based non-ICU HFNC protocols
Number of subjects: 36
Study 37051799 — intervention group
Group type: COMPARATOR
Intervention: Age-based non-ICU HFNC protocols
Number of subjects: 36
Study 37051799 — intervention group
Group type: COMPARATOR
Intervention: ICU-only HFNC protocols
Number of subjects: 36
Study 37051821 — intervention group
Group type: EXPERIMENTAL
Intervention: Glenohumeral joint corticosteroid injection
Number of subjects: 40
Study 37051821 — intervention group
Group type: COMPARATOR
Intervention: Suprascapular nerve block
Number of subjects: 40
Study 37051919 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 1107
Study 37051919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1107
Study 37051976 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip mobilisations along with strengthening exercises of hip and conventional knee exercises
Number of subjects: 66
Study 37051976 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening exercises of hip along with conventional knee interventional exercises
Number of subjects: 66
Study 37051976 — intervention group
Group type: COMPARATOR
Intervention: Conventional knee exercises only
Number of subjects: 66
Study 37051980 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting during Ramadan (Group A)
Number of subjects: 52
Study 37051980 — intervention group
Group type: COMPARATOR
Intervention: Not fasting during Ramadan (Group B)
Number of subjects: 52
Study 37051980 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-glucose cotransporter 2 (Group A)
Number of subjects: 52
Study 37052067 — intervention group
Group type: EXPERIMENTAL
Intervention: Head elevation
Number of subjects: 174
Study 37052067 — intervention group
Group type: COMPARATOR
Intervention: Simple head extension
Number of subjects: 174
Study 37052073 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (5 to 10 kg)
Number of subjects: 60
Study 37052073 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (10 to 20 kg)
Number of subjects: 60
Study 37052073 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (20 to 40 kg)
Number of subjects: 60
Study 37052073 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 37052108 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR (Eye Movement Desensitization and Reprocessing)
Number of subjects: 0
Study 37052108 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 37052120 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30
Number of subjects: 0
Study 37052133 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized strategy
Number of subjects: 1182
Study 37052133 — intervention group
Group type: COMPARATOR
Intervention: Restrictive strategy
Number of subjects: 1182
Study 37052133 — intervention group
Group type: COMPARATOR
Intervention: Liberal strategy
Number of subjects: 1182
Study 37052133 — intervention group
Group type: EXPERIMENTAL
Intervention: All strategies
Number of subjects: 1182
Study 37052216 — intervention group
Group type: COMPARATOR
Intervention: Indoor solar lighting systems
Number of subjects: 80
Study 37052316 — intervention group
Group type: EXPERIMENTAL
Intervention: Public healthcare system during the COVID-19 pandemic (2020)
Number of subjects: 36559
Study 37052316 — intervention group
Group type: COMPARATOR
Intervention: Private healthcare system during the COVID-19 pandemic (2020)
Number of subjects: 36559
Study 37052316 — intervention group
Group type: COMPARATOR
Intervention: Pre-pandemic period (2019)
Number of subjects: 36559
Study 37052557 — intervention group
Group type: EXPERIMENTAL
Intervention: MHO group
Number of subjects: 120
Study 37052557 — intervention group
Group type: COMPARATOR
Intervention: MUHO group
Number of subjects: 120
Study 37052557 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased body mass index
Number of subjects: 120
Study 37052562 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR (Fractional Flow Reserve derived from invasive coronary angiography)
Number of subjects: 250
Study 37052562 — intervention group
Group type: COMPARATOR
Intervention: Invasive FFR (control)
Number of subjects: 250
Study 37052578 — intervention group
Group type: EXPERIMENTAL
Intervention: ProFit score (intervention for assessing prosthetic fit and alignment)
Number of subjects: 113
Study 37052667 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical correction with or without patching
Number of subjects: 32
Study 37052667 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasses with patching
Number of subjects: 32
Study 37052667 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasses alone
Number of subjects: 32
Study 37052688 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB)
Number of subjects: 24
Study 37052688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 37052803 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD10 (10 mg/kg/day)
Number of subjects: 396
Study 37052803 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD20 (20 mg/kg/day)
Number of subjects: 396
Study 37052803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study 37052821 — intervention group
Group type: EXPERIMENTAL
Intervention: sintilimab + modified FOLFIRINOX (mFFX)
Number of subjects: 110
Study 37052821 — intervention group
Group type: COMPARATOR
Intervention: modified FOLFIRINOX (mFFX)
Number of subjects: 110
Study 37052913 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 172
Study 37052913 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography plus CEUS
Number of subjects: 172
Study 37052913 — intervention group
Group type: COMPARATOR
Intervention: Scintigraphy
Number of subjects: 172
Study 37052929 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-fitting OTC hearing aid with remote support
Number of subjects: 68
Study 37052929 — intervention group
Group type: COMPARATOR
Intervention: Audiologist-fitted hearing aid
Number of subjects: 68
Study 37052965 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus carboplatin and paclitaxel (n=63)
Number of subjects: 125
Study 37052965 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin and paclitaxel (n=62)
Number of subjects: 125
Study 37053050 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie feeding
Number of subjects: 22
Study 37053050 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting
Number of subjects: 22
Study 37053246 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential bilateral accelerated theta burst stimulation (aTBS) administered as 3 sessions daily for 10 days, with 1,800 pulses delivered continuously to the right DLPFC and intermittently to the left DLPFC.
Number of subjects: 0
Study 37053246 — intervention group
Group type: COMPARATOR
Intervention: Sham TBS treatment administered as 3 sessions daily for 10 days.
Number of subjects: 0
Study 37053376 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrointestinal bleeding patients
Number of subjects: 116
Study 37053413 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE intervention (mobile-based application with personalized content and cognitive behavioral skills training)
Number of subjects: 485
Study 37053413 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 485
Study 37053429 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy
Number of subjects: 49
Study 37053429 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Number of subjects: 49
Study 37053429 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-brain stimulation
Number of subjects: 49